---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083447"
form_type: "8-K"
ticker: "MBX"
cik: "0001776111"
company_name: "MBX Biosciences, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:23:29.895259+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# MBX Biosciences posts updated corporate presentation; no material financial or pipeline updates disclosed

## Summary
- Company posted updated corporate presentation on its website on June 9, 2025.
- Presentation is dated June 2025 and features the 'Precision Endocrine Peptides' tagline.
- No specific data on clinical programs, financials, or guidance changes were provided in the filing.
- Exhibit 99.1 (presentation) was only partially reproduced; full content not available for analysis.

## SEC filing metadata
- accession: 0000950170-25-083447
- form_type: 8-K
- ticker: MBX
- cik: 0001776111
- company_name: MBX Biosciences, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1776111/000095017025083447/0000950170-25-083447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1776111/000095017025083447/mbx-20250609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083447
- JSON: https://secwatch.observer/filing/0000950170-25-083447.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.